Fahrettin Kelestimur

Prof. Fahrettin Kelestimur


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2019 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
BYBayram Yilmaz
Bayram Yilmaz
HTHakan Terekeci
Hakan Terekeci
SSSuleyman Sandal
Suleyman Sandal
FKFahrettin Kelestimur
Fahrettin Kelestimur

1 December 2003 in Pituitary
Verified
Journal Article
Closed access
PDF file
FKFahrettin Kelestimur
Fahrettin Kelestimur

1 March 2010 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
ZKZ Karaca
Z Karaca
FTF Tanriverdi
F Tanriverdi
KUK Unluhizarci
K Unluhizarci
FKFahrettin Kelestimur
Fahrettin Kelestimur
Major hormonal changes emerge during pregnancy. The pituitary gland is one of the most affected organs with altered anatomy and physiology. The pituitary gland is enlarged as a result of lactotroph hyperplasia. Due to physiological changes in the pituitary and target hormone levels, binding globulins, and placental hormones, hormonal evaluation becomes more complex in pregnant women. As a consequence of physiological hormonal changes, the evaluation of pituitary functions in pregnant women is quite different from that done in the prepregnant state. Pituitary adenomas may cause problems by their hormone secretion that affects the mother and the fetus besides causing an increased risk of tumor growth. Furthermore, diagnosis, course, and treatment of pituitary diseases point out differences. The changes in anatomy and physiology of the pituitary gland during pregnancy are reviewed. Pituitary disorders namely Cushing's disease; acromegaly; prolactinoma; TSH-secreting, gonadotropin-producing, and clinically nonfunctioning adenomas; craniopharyngioma; and Sheehan's syndrome, which is one of the most common causes of hypopituitarism, lymphocytic hypophysitis, and hypopituitarism, in relation to pregnancy are discussed. Being aware of all this information will prevent any serious problems which mother and child will be exposed to.

1 January 2007 in Stress
Verified
Journal Article
Closed access
FTF. Tanriverdi
F. Tanriverdi
ZKZ. Karaca
Z. Karaca
KUK. Unluhizarci
K. Unluhizarci
FKFahrettin Kelestimur
Fahrettin Kelestimur
The hypothalamo–pituitary–adrenal (HPA) axis plays a major role in the regulation of responses to stress. Human stress-related disorders such as chronic fatigue syndrome (CFS), fibromyalgia syndrome (FMS), chronic pelvic pain and post-traumatic stress disorder are characterized by alterations in HPA axis activity. However, the role of the HPA axis alterations in these stress-related disorders is not clear. Most studies have shown that the HPA axis is underactive in the stress-related disorders, but contradictory results have also been reported, which may be due to the patients selected for the study, the methods used for the investigation of the HPA axis, the stage of the syndrome when the tests have been done and the interpretation of the results. There is no structural abnormality in the endocrine organs which comprise the HPA axis, thus it seems that hypocortisolemia found in the patients with stress-related disorder is functional. It may be also an adaptive response of the body to chronic stress. In this review, tests used in the assessment of HPA axis function and the HPA axis alterations found in CFS and FMS are discussed in detail.

15 January 2007 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
FTFatih Tanriverdi
Fatih Tanriverdi
KUKursad Unluhizarci
Kursad Unluhizarci
BCBekir Coksevim
Bekir Coksevim
ASAhmed Selcuklu
Ahmed Selcuklu
FCFelipe F. Casanueva
Felipe F. Casanueva
FKFahrettin Kelestimur
Fahrettin Kelestimur

15 August 2013 in Journal of Neurotrauma
Verified
Journal Article
Closed access
FTFatih Tanriverdi
Fatih Tanriverdi
ABAnnamaria De Bellis
Annamaria De Bellis
HUHalil Ulutabanca
Halil Ulutabanca
ABAntonio Bizzarro
Antonio Bizzarro
ASAntonio A. Sinisi
Antonio A. Sinisi
FKFahrettin Kelestimur
Fahrettin Kelestimur
Traumatic brain injury (TBI) has been recently recognized as a common cause of pituitary dysfunction. However, there are not sufficient numbers of prospective studies to understand the natural history of TBI induced hypopituitarism. The aim was to report the results of five years' prospective follow-up of anterior pituitary function in patients with mild, moderate and severe TBI. Moreover, we have prospectively investigated the associations between TBI induced hypopituitarism and presence of anti-hypothalamus antibodies (AHA) and anti-pituitary antibodies (APA). Twenty five patients (20 men, five women) were included who were prospectively evaluated 12 months and five years after TBI, and 17 of them also had a third-year evaluation. Growth hormone (GH) deficiency is the most common pituitary hormone deficit at one, three, and five years after TBI. Although most of the pituitary hormone deficiencies improve over time, there were substantial percentages of pituitary hormone deficiencies at the fifth year (28% GH, 4% adrenocorticotropic hormone [ACTH], and 4% gonadotropin deficiencies). Pituitary dysfunction was significantly higher in strongly AHA- and APA-positive (titers ≥1/16) patients at the fifth year. In patients with mild and moderate TBI, ACTH and GH deficiencies may improve over time in a considerable number of patients but, although rarely, may also worsen over the five-year period. However in severe TBI, ACTH and GH status of the patients at the first year evaluation persisted at the fifth year. Therefore, screening pituitary function after TBI for five years is important, especially in patients with mild TBI. Moreover, close strong associations between the presence of high titers of APA and/or AHA and hypopituitarism at the fifth year were shown for the first time.